is tirzepatide on the fda shortage list Compounders protest as removes off The Tirzepatide Shortage Is Over:

A qualified prescribing provider should match the medication and brand to the patients clinical situation, contraindications, treatment goals, and insurance requirements

If you want GLP-1 weight loss with a clinic that stays involved, give us a call or book a consult and lets build a plan that fits your body and your life.

Poor GLP-1 injection technique and inadequate site rotation are the primary risk factors

Clinicians should consider several potential concerns during evaluation: Unknown active ingredient source Variable potency or concentration Differences in excipients Sterility concerns for injectable products Dosing inaccuracies Limited stability data Inconsistent patient instructions The FDA has also warned healthcare professionals about compounded products made with salt forms of semaglutide that differ from the approved active ingredient

Call 403.452.5699 Book a Consultation